Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.160
+0.110 (3.61%)
At close: Dec 16, 2025, 4:00 PM EST
3.280
+0.120 (3.80%)
Pre-market: Dec 17, 2025, 5:44 AM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.22 billion as of December 17, 2025. Its market cap has increased by 53.44% in one year.
Market Cap
1.22B
Enterprise Value
436.91M
1-Year Change
53.44%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has increased from $1.14B to $1.22B, an increase of 7.21%. That is a compound annual growth rate of 0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 1.21B | 56.68% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |